In a rare ruling for a condemned prisoner, the justices would not let Alabama use a contested method of execution. By Adam Liptak Adam Liptak is the chief legal correspondent and host of The Docket.
Google is certainly devoting a lot of attention to an agent-driven scientific future. The big scientific announcement at I/O was the new Gemini for Science package, which unites several of the company ...
10don MSN
A jury voted for Jeffery Lee to receive a life sentence. Alabama plans to execute him anyway
Jeffery Lee faces execution Thursday because a judge overturned a jury’s vote for a life sentence under a since-abolished ...
METR, which runs the benchmark measuring how well models can complete long-duration tasks, found that Claude Mythos Preview could work for “at least” 16 hours and was “at the upper end of what [METR] ...
Essential Tips to Run PowerShell Scripts Like a Pro PowerShell has evolved into a powerful scripting language that’s essential for system administrators and IT professionals alike. Whether you’re ...
Artificial intelligence agents seem to have created their own religion, Crustafarianism. Is that possible?
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Alabama is seeking to execute a man with lethal injection hours after his nitrogen execution was prevented from going forward ...
Graduates are coming into the workforce thinking that using AI is cheating, a top Deloitte exec says
Colleges are failing to prepare students for an AI-driven workplace by teaching many of them to treat the technology as cheating, according to Rob Hillard, the CEO of Deloitte's Asia-Pacific branch.
It’s been three-and-a-half years since generative AI exploded onto the scene. In this past year, progress has continued its relentless pace: Vibe coding took off, companies embraced agentic workflows, ...
Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results